TrialNeuro-oncology2015
Dynamic susceptibility contrast MRI measures of relative cerebral blood volume as a prognostic marker for overall survival in recurrent glioblastoma: results from the ACRIN 6677/RTOG 0625 multicenter trial.
Kathleen M Schmainda et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
79 papers cite itlatest 60 shown
this paperpooled ittrialcites it